Fluorodeoxyglucose (FDG) positron emission tomography combined with computed tomography (PET/CT) has become indispensable in the management of haematological malignancies. By visualising and ...

Expert Rev Anticancer Ther. 2009;9(1):75-96. Based on the available data, FDG-PET alone appears to be of limited use in differentiating tumors of low malignant potential from benign tumors and ovarian ...

For patients with head and neck squamous cell carcinoma, utilizing fluorodeoxyglucose-(FDG)-PET/CT imaging to assess their response to chemoradiation significantly increases the accuracy in ...

PET/CT can add valuable information to aid the diagnosis of fever of unknown origin (FUO), according to a new multicenter, ...

An analysis of published studies has found that FDG-PET is less effective at diagnosing lung cancer compared to other kinds of benign lung diseases in geographic areas where those diseases are more ...

For patients with giant cell arteritis (GCA), a higher total vascular score (TVS) based on 18 F-fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging at diagnosis is associated with a ...

At the San Antonio Breast Cancer Symposium, Jennifer Specht, MD, of the University of Washington and Fred Hutch Cancer Center, Seattle, presented results from the ECOG-ACRIN FEATURE trial, a phase II ...

Advances in nuclear medicine are helping doctors diagnose childhood cancers more accurately, monitor treatment more ...

Academic Medical Centers and ASCO Recommendations: Starting a Difficult Discussion Table 1. Summary of the Recommendation of the EANM-SNMMI, NCCN, ESMO, and ABC Considering Imaging Modalities to be ...

A first-in-class peptide-based PET tracer, 18 F-AlF-NOTA-PCP2, can effectively measure PD-L1 expression in patients with head and neck cancers, outperforming the conventional tracer 18 F-FDG. 18 F-AlF ...